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Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is
an important second messenger in signaling pathways
in organisms ranging from yeast to mammals, but the
regulation of PI(4,5)P2 levels remains unclear. Here we
present evidence that PI(4,5)P2 levels in Saccharomyces
cerevisiae are down-regulated by the homologous and
functionally redundant proteins TAX4 and IRS4. The
EPS15 homology domain-containing proteins TAX4 and
IRS4 bind and activate the PI(4,5)P2 5-phosphatase
INP51 via an Asn-Pro-Phe motif in INP51. Furthermore,
the INP51-TAX4/IRS4 complex negatively regulates the
cell integrity pathway. Thus, TAX4 and IRS4 are novel
regulators of PI(4,5)P2 and PI(4,5)P2-dependent signal-
ing. The interaction between TAX4/IRS4 and INP51 is
analogous to the association of EPS15 with the 5-phos-
phatase synaptojanin 1 in mammalian cells, suggesting
that EPS15 is an activator of synaptojanin 1.
Phosphoinositides are conserved from yeast to mammals as
second messengers. They mediate the signal transduction in-
volved in many different cellular processes and thereby com-
prise a complex signaling system (1). One of the more thor-
oughly studied phosphoinositides is phosphatidylinositol 4,5-
bisphosphate (PI(4,5)P2).
1 PI(4,5)P2 was originally shown to be
cleaved by phospholipase C to generate the two second mes-
sengers inositol-1,4,5-phosphate and diacylglycerol (2). More
recently, uncleaved PI(4,5)P2 has also been shown to act as a
second messenger (3). Uncleaved PI(4,5)P2 acts by binding
conserved domains in target proteins, such as the pleckstrin
homology domain (4–6). In mammalian cells, PI(4,5)P2 signal-
ing is important in regulating vesicular transport, the organi-
zation of the actin cytoskeleton, and the regulation of ion chan-
nels (7–9). In the model organism Saccharomyces cerevisiae,
PI(4,5)P2 is also essential and is produced by MSS4, the sole
phosphatidylinositol 4-phosphate 5-kinase in yeast (10, 11).
One target of PI(4,5)P2 signaling in S. cerevisiae is the GDP/
GTP exchange factor ROM2. ROM2 contains a pleckstrin ho-
mology domain that binds PI(4,5)P2 in the plasma membrane,
thus mediating the localization of ROM2 (12, 13). ROM2 has
two homologs, ROM1 and TUS1, which also harbor putative
pleckstrin homology domains (12, 14). ROM2 and its homologs
are components of the cell integrity pathway necessary for the
cellular response to cell wall damage induced by stress such as
heat shock (14, 15). The response to cell wall damage includes
a reorganization of the actin cytoskeleton and an up-regulation
of cell wall synthesis (16–18). Activation of the cell integrity
pathway is mediated by its most upstream component, the cell
wall sensor WSC1, which signals to ROM2 (19, 20). Subse-
quently, ROM2 stimulates the exchange of GDP to GTP in the
Rho GTPase RHO1, thereby activating RHO1 (12). The GT-
Pase-activating protein (GAP) SAC7 converts RHO1-GTP into
the inactive GDP-bound form (21). RHO1 in its active (GTP-
bound) form has several effectors such as the glucan synthase
FKS1 and the PKC1-MAP kinase cascade (22–25). Activation of
the MAP kinase MPK1 induces transcription of genes involved
in cell wall biosynthesis such as CHS3 encoding chitin syn-
thase III, which is important for cell wall repair (16, 18, 26).
The ROM2-MAP kinase-signaling pathway is also an effector
branch of the TOR signaling network. The TOR signaling net-
work contains two structurally and functionally distinct com-
plexes, TOR complex 1 (TORC1) and 2 (TORC2) (27). TORC2
regulates the polarization of the actin cytoskeleton, and this
regulation is via the ROM2-MAP kinase pathway (21, 27–29).
Interestingly, the sole phosphatidylinositol 4-phosphate 5-ki-
nase MSS4 is required for the polarization of the actin cytoskel-
eton, and overexpression of MSS4 restores growth in condi-
tional TORC2 mutants (10, 11, 27, 30). However, the link
between PI(4,5)P2 and TORC2 in the regulation of ROM2 and,
ultimately, the actin cytoskeleton is not understood.
The phosphoinositide 5-phosphatases INP51, INP52, and
INP53 (also known as SJL1–3) mediate the turnover of
PI(4,5)P2 and are implicated in several cellular processes such
as cell wall biosynthesis and the organization of the actin
cytoskeleton (31, 32). Heat shock has been observed to induce
an increase in PI(4,5)P2 levels, suggesting the existence of a
mechanism regulating the levels of this phosphoinositide (10).
However, the nature of this regulatory mechanism and, more
specifically, the possible regulation of the phosphoinositide
5-phosphatases are not well understood. In mammalian cells,
the INP family orthologue synaptojanin 1 interacts with sev-
eral proteins involved in endocytosis in nerve terminals (33–
35). To investigate the regulation of PI(4,5)P2 turnover in
S. cerevisiae, we focused on INP51, INP52, and INP53 and
their role in PI(4,5)P2 signaling linked to the cell integrity
pathway and the TORC2 pathway.
Here we present evidence for two novel positive regulators of
the PI(4,5)P2 5-phosphatase INP51, the redundant EPS15 ho-
mology (EH) domain-containing proteins TAX4 and IRS4.
INP51 associates with TAX4 or IRS4 to form a complex impor-
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tant for the turnover of PI(4,5)P2 linked to the cell integrity
pathway.
EXPERIMENTAL PROCEDURES
Strains and Media—The S. cerevisiae strains used in this study are
listed in Table I. All strains were isogenic derivatives of TB50. Rich
medium (yeast extract, peptone, and dextrose (YPD)) and minimal
medium (synthetic dextrose (SD)) were as described previously (36).
PCR cassettes were used to generate gene deletions and for tagging
with HA, Myc, or the tandem affinity purification tag, as described
(37–39). Yeast transformation was performed by the lithium acetate
procedure (40). Correct integration was verified by PCR, and tagged
proteins were tested for their functionality.
Spot Assay—Logarithmically growing cells were harvested and re-
suspended in 10 mM Tris-HCl (pH 7.4). The resuspended cells were
diluted in a 10-fold dilution series. 3 l of each dilution (10, 100,
1,000 and 10,000 diluted) were spotted on a YPD plate. Growth was
scored after 2 days at 30 or 37 °C.
INP51 Purification—Cells expressing a tagged or untagged (mock
purification) version of INP51 were grown in 5 liters of YPD to an A600
of 0.8 at 30 °C, harvested by centrifugation, and washed with cold water
before resuspension in lysis buffer. The lysis buffer used to prepare cell
extracts contained phosphate-buffered saline, 5% glycerol. 0.5% Tween
20, phosphatase inhibitors (10 mM NaF, 10 mM NaN3, 10 mM p-nitro-
phenylphosphate, 10 mM sodium pyrophosphate, 10 mM -glycerophos-
phate, and 1 mM phenylmethylsulfonyl fluoride), and protease inhibitor
mixture tablets (Roche Applied Science). Cell lysate was obtained by
glass bead lysis. Cell lysates containing 700 mg of protein were
cleared with a 5-min, 500 g spin, diluted with lysis buffer to 10 mg/ml,
and subsequently passed over an ion exchange resin (SP-Sepharose).
The resin was washed twice with lysis buffer and twice with lysis buffer
containing 50 mM potassium acetate. Bound proteins were eluted with
lysis buffer containing 600 mM potassium acetate. The eluate was
precleared over a protein A-Sepharose (Amersham Biosciences) column
prior to the addition of anti-HA (12CA5) cross-linked to protein A-
Sepharose beads. After 5 times washing with lysis buffer, immunopre-
cipitated proteins were visualized by silver staining (41). Analysis of
protein bands by mass spectrometry was performed as described (27).
Immunoprecipitation—Yeast extracts from cells (500-ml culture in
YPD grown to A600 of 0.8 at 30 °C) expressing tagged proteins of interest
were prepared as described above. An aliquot of extract containing 10
mg of protein was adjusted to 1 ml with lysis buffer plus inhibitors. For
immunoprecipitations, 20 l of anti-HA (12CA5) or anti-Myc (9E10)
cross-linked to protein A-Sepharose beads were added and mixed for 4 h
at 4 °C. Beads were collected by centrifugation, washed five times with
1 ml of lysis buffer, and resuspended in 5 SDS-polyacrylamide gele
sample buffer for electrophoresis. After SDS-PAGE, the proteins were
blotted onto nitrocellulose membranes, blocked in 5% dry milk powder
in 1 phosphate-buffered saline and 0.1% Nonidet P-40, and incubated
with primary antibody anti-HA (clone 12CA5) or anti-Myc (clone 9E10)
(1:10000 in blocking solution). Subsequently tagged proteins were de-
tected using horseradish peroxidase-conjugated goat anti-mouse sec-
ondary antibodies and ECL reagents (Amersham Biosciences).
Phosphoinositide Analysis—Yeast cells were diluted 5  104/ml in
SD medium lacking inositol containing 10 C/ml [3H]inositol and grown
to a density of 2–4  106/ml (12–16 h). 2-ml aliquots were taken and
mixed with 2 ml of MeOH. Cells were pelleted by centrifugation and
processed as described previously (42).
Differential Centrifugation—Differential centrifugation was per-
formed as described previously (43).
Indirect Immunofluorescence—Logarithmically growing cells con-
taining INP51-HA, TAX4-Myc, or IRS4-Myc were fixed for 2 h in the
growth medium supplemented with formaldehyde (3.7% final) and po-
tassium phosphate buffer (100 mM final, pH 6.5). Cells were washed
and resuspended in sorbitol buffer (1.2 M sorbitol and 100 mM potassium
phosphate, pH 6.5). Cell walls were digested for 45 min at 37 °C in
sorbitol buffer supplemented with -mercaptoethanol (20 mM final) and
zymolyase 20T (12.5 mg/ml; Seigagaku Corporation). Spheroblasts were
fixed on poly-L-lysine-coated glass slides and permeabilized with PBT
(53 mM Na2HPO4, 13 mM NaH2PO4, 75 mM NaCl, 1% bovine serum
albumin, and 0.1% Triton X-100). Immunofluorescence directed against
the HA epitope was performed by application of a primary antibody
anti-HA (clone 12CA5) or anti-Myc (clone 9E10) at a dilution of 1:1,000
in PBT for 2 h and, subsequently, the application of a Cy3-conjugated
rabbit anti-mouse IgG (Molecular Probes) diluted 1:1,000 in PBT for 90
min. Washed cells were examined with a Zeiss Axiophot microscope
(100 objective). Immunofluorescent detection of FKS1 was performed
as described previously (17).
MAP Kinase Activation Assay—YPD cultures of logarithmically
growing cells at 24 or 39 °C were harvested, and cell extracts were
prepared as described previously (44). Protein concentrations of ex-
tracts were determined by using a Bradford assay (Bio-Rad). Samples
were denatured by the addition of 5 SDS-PAGE sample loading buffer
and heating at 95 °C for 5 min. A total of 25 g of protein (for MPK1
protein detection) or 40 g of protein (for phosphorylated MAP kinase
detection) was loaded for standard SDS-PAGE (10% acrylamide) and
Western blot. For immunodetection, a goat anti-MPK1 antibody (clone
yN-19, 1:1000 dilution; Santa Cruz Biotechnology) and a rabbit anti-
phospho-p44/42 MAP kinase (Thr202/Tyr204) antibody (1:1000; Cell
Signaling) were used. The anti-MPK1 and anti-phospho-MAP kinase
were verified to specifically recognize activated MPK1 under heat stress
conditions (data not shown). Secondary antibodies were horseradish
peroxidase-conjugated anti-goat (anti-MPK1) or anti-rabbit (anti-phos-
pho-MAP kinase) secondary antibody and detection by ECL reagents
(Amersham Biosciences). The nitrocellulose membrane used for the
Western blot was stained with Coomassie Blue for the visualization of
total protein.
TABLE I
Strains used in this study
Strain Genotype
TB50a MATa leu2–3,112 ura3–52 trp1 his3 rme1 HMLa
PA66-2A TB50a wsc1::HIS3MX6
TS124-2A TB50a rom2::kanMX4
SF8-2D TB50a sac7::kanMX4
SF36-2B TB50a tor2::kanMX4/YCplac33::tor2–21ts
HM44-1C TB50 inp51::HIS3MX6
HM47-1C TB50a INP51-HA3-kanMX4
HM52-2D TB50 inp51::HIS tor2::kanMX4/YCplac33::tor2–21ts
HM59-2C TB50a inp51::HIS rom2::kanMX4
HM64-1B TB50a inp51::HIS wsc1::HIS3MX6
HM77-1B TB50a inp51::HIS sac7::kanMX4
HM90-1A TB50a irs4::kanMX4
HM92-1A TB50 TAX4-MYC13-HIS3MX6
HM93-1A TB50 tax4::HIS3MX6
HM96-1B TB50a INP51-HA3-kanMX4 TAX4-MYC13-HIS3MX6
HM102-3B TB50a INP51NPF-HA3-HIS3MX6
HM104-2D TB50 IRS4-MYC13-HIS3MX6
HM112-2C TB50 tax4::HIS3MX6 irs4::kanMX4
HM119-2B TB50a INP51-HA3-kanMX4 IRS4-MYC13-HIS3MX6
HM122-9B TB50a tax4::HIS3MX6 irs4::kanMX4 sac7::kanMX4
HM125-1A TB50 tax4::HIS3MX6 irs4::kanMX4 tor2::kanMX4/YCplac33::tor2–21ts
HM127-3B TB50a INP51NPF-HA3-HIS3MX6 TAX4-MYC13-HIS3MX6
HM132-2D TB50a INP51NPF-HA3-HIS3MX6 IRS4-MYC13-HIS3MX6
5-Phosphatase Regulation 39605
 at U
niversitaetsbibliothek M
edizin on N
ovem
ber 8, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Actin Staining—Logarithmically growing cells were fixed in formal-
dehyde (3.7%) and potassium phosphate buffer (100 mM, pH 6.5) and
stained with TRITC-phalloidin (Sigma) to visualize actin, as described
previously (45).
Chitin Staining—1 ml of cells at an A600 of 0.5 were collected by
centrifugation and washed with water. Cells were then incubated in a
solution with 0.5 mg/ml calcofluor white (Sigma) for 5 min to visualize
chitin. To remove residual calcofluor white, cells were washed twice
with water. Cells were examined with a Zeiss Axiophot microscope
(100 objective).
RESULTS
Disruption of INP51 Restores Growth of a tor2 Mutant—To
understand further how the turnover of PI(4,5)P2 is important
for PI(4,5)P2 signaling, we tested whether the phosphoinositide
5-phosphatase INP51, INP52, or INP53 antagonizes MSS4 sig-
naling. We asked if the lack of any INP gene mimics MSS4
overexpression in suppressing a TOR2 signaling defect. A de-
letion of each INP gene was introduced into a temperature-
sensitive tor2 (tor2ts) mutant defective in the organization of
the actin cytoskeleton. The double mutants were grown at
permissive (30 °C) and restrictive (37 °C) temperatures to de-
termine whether an INP mutation can suppress the tor2ts
mutation. Deletion of only INP51, INP52, or INP53 conferred
no growth defect at any temperature (data not shown). Inter-
estingly, the deletion of INP51, but not the deletion of INP52 or
INP53, suppressed the growth defect of tor2ts cells (data not
shown). The inp51 tor2ts cells grew almost as well as wild-type
cells and as well as tor2ts cells overexpressing MSS4 (Fig. 1).
This result suggests that INP51, but not INP52 or INP53,
antagonizes the role of MSS4 in the TORC2 signaling pathway.
Curiously, although inp51 suppressed the growth defect of
tor2ts, it did not appear to suppress the actin defect of the tor2ts
mutant (data not shown).
INP51 Synthetically Interacts with Mutations Affecting the
Cell Integrity Pathway—The finding that an inp51 deletion
suppresses the growth defect of a tor2ts mutant is similar to the
previous observation that activation of the cell integrity path-
way suppresses the growth defect of a tor2ts mutant (15) and
suggests that INP51 may antagonize the cell integrity path-
way. Thus, we investigated whether an inp51 mutation inter-
acts with mutations affecting components of the cell integrity
pathway. Specifically, we asked if an inp51 deletion suppresses
or enhances the effect of mutations in WSC1, ROM2, SAC7, or
MPK1. We observed that the deletion of INP51 suppresses the
growth defects of wsc1 and rom2 cells at 37 and 30 °C, the
restrictive temperatures of these mutants, respectively (Fig. 2,
A and B). Conversely, the combination of inp51 with sac7
conferred a synthetic growth defect (Fig. 2C). Finally, the
growth defect of an mpk1 mutant grown at restrictive temper-
ature (38 °C) was not suppressed by INP51 deletion (data not
shown). The above results show that INP51 genetically inter-
acts with at least some components of the cell integrity path-
way. Deletion of INP51 suppresses mutations in positive com-
ponents of the pathway (WSC1 and ROM2) and causes a
synthetic defect when combined with a mutation in a negative
element of the pathway (SAC7). The nature of these interac-
tions suggests that the phosphoinositide phosphatase INP51
negatively regulates signaling through the cell integrity path-
way. This conclusion is consistent with the previous conclu-
sions (13, 27, 30, 46) that the phosphoinositide kinase MSS4
and PI(4,5)P2 act positively on the TORC2 and cell integrity
pathways.
INP51 Associates with the EH Domain-containing Proteins
TAX4 and IRS4—In mammalian cells, the kinases and phos-
phatases that determine PI(4,5)P2 levels are regulated by in-
teracting proteins (33, 47–51). An indication that the level of
PI(4,5)P2 is regulated in S. cerevisiae has been suggested pre-
viously by the observation that PI(4,5)P2 levels increase upon
heat shock (10). However, proteins regulating such kinases and
phosphatases in S. cerevisiae remain to be identified. To iden-
tify potential INP51 regulatory proteins, we opted to isolate
INP51-interacting proteins by using a biochemical approach
described previously (27). A functional, epitope-tagged version
of INP51 (INP51-HA) was constructed and purified from yeast
cell extracts as described under “Experimental Procedures.”
Two homologous proteins were co-purified with INP51, IRS4,
and an uncharacterized protein encoded by the open reading
frameYJL083w that we named TAX4 (Fig. 3). The interaction
between INP51 and TAX4 or IRS4 was confirmed by coimmu-
noprecipitation using epitope-tagged versions of TAX4 (TAX4-
Myc) and IRS4 (IRS4-Myc), as described under “Experimental
Procedures” (Fig. 4). We did not observe interaction between
TAX4 and IRS4 by coimmunoprecipitation of the heterolo-
gously tagged versions (TAX4-TAP and IRS4-Myc) of these
proteins (data not shown). IRS4 was identified previously in a
screen for mutants defective in rDNA silencing (52). Untagged
TAX4 has an apparent molecular mass of 77 kDa and a pre-
dicted size of 68.7 kDa. Untagged IRS4 is observed as two
bands between 70 and 75 kDa, slightly larger than the pre-
dicted size of 68.8 kDa. TAX4 and IRS4 have an overall identity
of 31% and contain a C-terminal EH domain. The EH domains
FIG. 1. Disruption of INP51 restores growth of a tor2 temper-
ature-sensitive mutant (tor2ts). Wild-type (TB50a), inp51, tor2ts,
and tor2ts inp51 cells and tor2ts cells transformed with plasmid overex-
pressing MSS4 were spotted on to YPD medium and incubated at 30 or
37 °C. tor2ts cells are not viable at 37 °C.
FIG. 2. INP51 synthetically interacts with mutations affecting
the cell integrity pathway. A, wild-type, inp51, wsc1, and wsc1 inp51
cells were spotted on to YPD medium and incubated at 30 or 37 °C. wsc1
has a growth defect at 37 °C. B, wild-type, inp51, rom2, and rom2 inp51
cells were spotted onto YPD medium and incubated at 30 °C. The rom2
mutant has a growth defect at 30 °C. C, wild-type, inp51, sac7, and sac7
inp51 cells were spotted onto YPD medium and incubated at 30 °C.
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of TAX4 and IRS4 are 64% identical. The EH domain, con-
served from yeast to human, is a protein-protein interaction
domain of 100 amino acids that interacts specifically with
short motifs containing an asparagine-proline-phenylalanine
(NPF) core (53, 54). INP51 has a C-terminal NPF motif (55),
amino acids 932–934, which is important for the interaction
between INP51 and TAX4 or IRS4. The absence of the NPF
motif and amino acids C-terminal to NPF in INP51 (i.e. the
deletion of amino acids 932–946) abolishes the interaction be-
tween INP51 and TAX4 or IRS4, as assayed by coimmunopre-
cipitation (Fig. 4). Our results show that INP51, via its NPF-
motif, interacts separately with the two EH domain-containing
proteins TAX4 and IRS4, suggesting that INP51 forms sepa-
rate INP51-TAX4 and INP51-IRS4 complexes.
There are additional EH-containing proteins in S. cerevisiae,
including PAN1, END3, and EDE1 (45, 56, 57). Interestingly, a
conditional pan1 mutation shows synthetic interaction with an
inp51 mutation (58). Because PAN1 and END3 belong to the
same protein complex, we tested whether PAN1 and/or END3
interact with INP51. We could not detect, by coimmunoprecipi-
tation, an interaction between INP51 and PAN1 or END3,
suggesting that INP51 interacts specifically with TAX4 and
IRS4.
TAX4 and IRS4 Positively Regulate INP51—The interaction
of INP51 with TAX4 and IRS4 led us to examine a possible
involvement of TAX4 and IRS4 in the function of INP51. TAX4
and IRS4 are non-essential genes, as shown previously (59).
Furthermore, cells lacking both TAX4 and IRS4 (a tax4 irs4
double mutant) did not display a detectable growth defect on
standard rich or minimal media at various temperatures (Fig.
6 and data not shown).
To determine the function of TAX4 and IRS4, we measured
the levels of all detectable S. cerevisiae phosphoinositides,
namely phosphatidylinositol 3-phosphate, phosphatidylinositol
4-phosphate, phosphatidylinositol 3,5-bisphosphate, and PI(4,5)P2,
in inp51, tax4, irs4, and tax4 irs4 mutant cells. The double mutant
tax4 irs4 was examined in anticipation of the likelihood that the
structurally homologous TAX4 and IRS4 proteins are also function-
ally homologous. We observed that an inp51 mutant has higher
levels of PI(4,5)P2 than does wild-type, as observed previously (60),
but is not altered in the levels of other phosphoinositides (Fig. 5).
The deletion of TAX4 or IRS4 did not affect the level of any phos-
phoinositide. However, the double deletion mutant tax4 irs4, like
the inp51 mutant, exhibited a significant and specific increase in
the level of PI(4,5)P2. Our data suggest that TAX4 and IRS4 indeed
act redundantly as positive regulators of INP51 activity and,
thereby, PI(4,5)P2 turnover.
Because TAX4 or IRS4 appears to be required for INP51 ac-
tivity, we asked if the tax4 irs4 double mutation, like inp51,
genetically interacts with TOR2 and components of the cell in-
tegrity pathway. We combined the tax4 irs4 double mutation
with tor2ts, rom2, or sac7. In agreement with the positive role of
TAX4 and IRS4 on INP51 activity, tax4 irs4 suppressed the
growth defect of a tor2ts mutant at a non-permissive temperature
to the same extent as did the deletion of INP51 or the overex-
pression of MSS4 (Fig. 6). The growth defect of a rom2 mutant
was also suppressed by the tax4 irs4 mutation (data not shown).
Finally, the combination of tax4 irs4 with a sac7 mutation pro-
duced a synthetic growth defect similar to the combination of
inp51 and sac7 (Fig. 7). Deletion of TAX4 or IRS4 alone showed
no synthetic interaction with components of the cell integrity
pathway (data not shown). Our results suggest that TAX4 or
IRS4, like INP51, is important for PI(4,5)P2 turnover linked to
TORC2 signaling and the cell integrity pathway.
To investigate the mechanism by which TAX4 and IRS4
regulate INP51, we examined the cellular localization of TAX4,
IRS4, and INP51 by indirect immunofluorescence on strains
expressing epitope-tagged versions of these proteins. We ob-
served an intracellular punctate staining pattern for both
TAX4 and IRS4 (data not shown). However, for unknown rea-
FIG. 3. INP51 co-purifies with TAX4 and IRS4. A silver-stained
gel of INP51 purification (see “Experimental Procedures”) from
HM47-1C cells (INP51-HA) and TB50 cells (mock purification) is
shown. Protein bands unique to the INP51 purification are indicated.
These bands were excised and identified by mass spectrometry (see
“Experimental Procedures”). Equivalent regions of the mock purifica-
tion were also excised to confirm the co-purification with INP51.
FIG. 4. INP51 coimmunoprecipitates with TAX4 and IRS4. Ly-
sates from cells expressing INP51-HA (HM47-1C), TAX4-Myc (HM92-1A),
IRS4-Myc (HM104-2D), or INP51NPF-HA (HM102-3B) or co-expressing
INP51-HA and TAX4-Myc (HM96-1B), INP51-HA and IRS4-Myc
(HM119-2B), INP51NPF-HA and TAX4-Myc (HM127-3B), or
INP51NPF-HA and IRS4-Myc (HM132-2D) were used to analyze the
interaction between INP51 and TAX4 and IRS4. IP, immunoprecipitation.
FIG. 5. PI(4,5)P2 is increased in inp51 and tax4 irs4 cells. Wild-
type, inp51, tax4, irs4, and tax4 irs4 cells were labeled at 30 °C with
[3H]inositol, and [3H]inositol-containing lipids from the cell extracts were
deacylated, separated by high pressure liquid chromatography, and quan-
tified. PI(3)P, phosphatidylinositol 3-phosphate; PI(4)P, phosphatidyli-
nositol 4-phosphate; PI(3,5)P2, phosphatidylinositol 3,5-bisphosphate.
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sons, we were unable to detect a signal for INP51 and were
thus unable to determine by this assay if TAX4 or IRS4 is
required for the correct localization of INP51. INP51 has pre-
viously been shown to be membrane-associated (31). However,
by differential centrifugation (see “Experimental Procedures”)
we observed that INP51 is a cytosolic protein and that this
localization did not change in a tax4 irs4 double mutant (data
not shown).
INP51, TAX4, and IRS4 Negatively Regulate MPK1—The
genetic interactions described above suggest that INP51, TAX4,
and IRS4 negatively regulate signaling through the cell integrity
pathway. However, the above experiments (and data not shown
for TAX4 and IRS4) did not reveal a genetic interaction between
MPK1 and the INP51 complexes. To investigate further a possi-
ble functional interaction between the MPK1 and the INP51
complexes, we examined MPK1 phosphorylation in wild-type
cells and mutant cells containing rom2, sac7, inp51, tax4, irs4,
tax4 irs4, or any possible combination of rom2 or sac7 with inp51,
tax4, irs4, or tax4 irs4. Upon stimulation of the cell integrity
pathway, MPK1 is phosphorylated and thereby activated (61).
MPK1 phosphorylation was analyzed with an anti-phospho-p44/
p42 MAP kinase antibody that also specifically recognizes the
phosphorylated form of MPK1. The amount of total MPK1 was
assayed with a separate antibody that recognizes all forms of
MPK1. As shown previously, MPK1 phosphorylation is almost
undetectable in wild-type cells grown at 23 °C (non-inducing
condition) but increases upon shift to 39 °C (61). We examined
the phosphorylation state of MPK1 in wild-type cells and mutant
cells grown at low temperature (24 °C) and at high temperature
(39 °C). The level of MPK1 phosphorylation in heat-shocked cells
(shift to 39 °C for 30 and 60 min) was not altered in any of the
mutants examined (data not shown). However, the sac7, sac7
inp51, and sac7 tax4 irs4 mutations affected the basal level
(24 °C) of MPK1, as follows. A sac7 mutation resulted in a slight
increase in MPK1 phosphorylation but also a similar increase in
the amount of the MPK1 protein as compared with wild-type
(Fig. 8). The sac7 inp51 and sac7 tax4 irs4 cells exhibited a
10-fold increase in MPK1 phosphorylation and a 2.5-fold increase
in MPK1 protein level compared with the sac7 cells. Thus, inp51
and tax4 irs4 mutations cause constitutive MPK1 activity, al-
though this effect is detectable only when inp51 and tax4 irs4
mutations are combined with a sac7 mutation. Furthermore, as
suggested by some of the genetic interactions described above,
these findings confirm that INP51 complexes indeed negatively
regulate signaling through MPK1 and the cell integrity pathway.
The Distribution of Chitin Is Negatively Regulated by INP51,
TAX4, and IRS4—To further investigate the regulation of
MPK1 signaling by the INP51 complexes, we examined MPK1
readouts in sac7 inp51 and sac7 tax4 irs4 cells. In particular,
we examined the actin cytoskeleton, glucan synthase (FKS1)
and chitin (see the Introduction) in sac7, inp51, tax4 irs4, sac7
inp51, and sac7 tax4 irs4 cells grown at low (24 °C) and high
temperatures (39 °C). Heat stress transiently depolarizes both
the actin cytoskeleton and glucan synthase (17). The above
mutant cells behaved like wild-type cells with regard to the
actin cytoskeleton and FKS1 (data not shown), suggesting that
INP51, TAX4, and IRS4 do not regulate signaling of the cell
integrity pathway to these targets. However, the amount and
distribution of chitin was changed in some mutants. In wild-
type cells, chitin is most visible at the neck and at a future bud
site (Fig. 9). In the sac7 and tax4 irs4 cells the chitin signal was
slightly depolarized, whereas in the sac7 inp51 and sac7 tax4
irs4 cells the chitin signal and depolarization were strikingly
increased. In sac7 inp51 and sac7 tax4 irs4 cells, the chitin was
clearly distributed over the entire cell surface in unbudded
cells, the mother cell surface in small budded cells, and both
mother and daughter cell surfaces in large budded cells (Fig. 9).
The changes in chitin amounts and distribution suggest that
INP51, TAX4, and IRS4 regulate a specific branch of the cell
integrity pathway affecting chitin.
To investigate if the affect on chitin is the cause of the
observed growth defect of sac7 inp51 and sac7 tax4 irs4 cells
(Fig. 7), CHS3 was deleted in these mutants. CHS3 encodes
chitin synthase III that is responsible for 90% of the chitin
produced in the cell, although deletion of CHS3 does not cause
a growth defect (62–64). A deletion of CHS3 in sac7 inp51 and
sac7 tax4 irs4 mutants reduced the amount of chitin to wild-
type levels but did not suppress the growth defect (data not
shown). This suggests that targets of the cell integrity pathway
other than chitin could be affected (hyperactivated), thus caus-
FIG. 6. Double deletion of TAX4 and IRS4 restores growth of
tor2ts. Wild-type, inp51, tax4 irs4, tor2ts, tor2ts inp51, and tor2ts tax4
irs4 cells and tor2ts cells transformed with plasmid overexpressing
MSS4 were spotted onto YPD medium and incubated at 30 or 37 °C.
tor2ts cells are not viable at 37 °C.
FIG. 7. tax4 irs4 double mutation interact with mutations in
the cell integrity pathway. Wild-type, sac7, inp51, sac7 inp51, tax4
irs4, and sac7 tax4 irs4 cells were spotted onto YPD medium and
incubated at 30 °C.
FIG. 8. MPK1 activity increases in sac7 inp51 and sac7 tax4
irs4 cells. MPK1 activation and protein levels were analyzed in wild-
type, sac7, inp51, sac7 inp51, tax4 irs4, and sac7 tax4 irs4 cells at 24 °C.
Analysis of activated MPK1 with antibodies recognizing specific Thr/
Tyr phosphorylation (top section) and MPK1 protein level with antibod-
ies recognizing MPK1 (middle section) was performed. The bottom
section (total extract) shows a Coomassie-stained version of the gel from
the middle section. Equal amounts of protein were loaded in each lane,
i.e. 40 g for the gel of top section and 25 g for the gel of the middle and
bottom sections.
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ing the growth defect observed in sac7 inp51 and sac7 tax4 irs4
cells.
DISCUSSION
Here we present two proteins, TAX4 and IRS4, that are novel
partners of the phosphoinositide 5-phosphatase INP51. The
structurally homologous and functionally redundant TAX4 and
IRS4 proteins positively regulate INP51 activity and thereby
negatively regulate PI(4,5)P2 levels (Fig. 10). Furthermore, the
INP51 complexes (INP51-TAX4 and INP51-IRS4) negatively
regulate signaling through the cell integrity pathway, includ-
ing the MAP kinase MPK1.
TAX4 and IRS4 contain an EH domain. EH domains are
found mainly in proteins involved in endocytosis and the orga-
nization of the actin cytoskeleton, and they interact specifically
with short motifs containing an NPF core (54, 56, 57, 65, 66).
INP51 contains an NPF motif (55) that is important for the
interaction with TAX4 or IRS4 and is not found in any other
phosphoinositide phosphatase in S. cerevisiae. Thus, the inter-
action between INP51 and TAX4 or IRS4 is similar to the
interaction between the mammalian phosphoinositide 5-phos-
phatase synaptojanin 1 (NPF-containing) and EPS15, suggest-
ing a conserved regulatory mechanism (33). The functional
consequence of EPS15 binding to synaptojanin 1 is not known,
but our findings suggest that this binding may result in the
activation of synaptojanin 1 phosphatase activity.
How does TAX4 or IRS4 activate INP51? The EH domain has
been suggested to play an important role in recruiting proteins
to a specific cellular location (67). Our studies did not reveal a
change in INP51 localization in the absence of TAX4 and IRS4;
however, TAX4 and IRS4 might control a small pool of INP51
whose change in localization cannot be detected in the fraction-
ation experiment. Furthermore, we did not detect a change in
the binding of TAX4 or IRS4 to INP51 in response to several
different types of cell wall stress, including heat shock and
detergent treatment (data not shown). Future studies will be
required to determine the mechanism by which TAX4 or IRS4
activates INP51.
We also present evidence that INP51, TAX4, and IRS4 ge-
netically interact with two signaling pathways, the TORC2
signaling pathway and the cell integrity pathway (Fig. 10). The
mechanism by which inp51 and tax4 irs4 mutations suppress
the growth defect of a tor2 mutant remains unclear but could be
through the activation of the cell integrity pathway. The inp51
or tax4 irs4 mutations activate MPK1, and the cell integrity
pathway is a downstream effector pathway of TORC2. The
activation of MPK1, which is detected only when inp51 or tax4
irs4 is combined with a sac7 mutation, could be a result of
increased RHO1 activity (balance toward the active, GTP-
bound form of RHO1). The sac7 mutation eliminates a RHO1
GAP and thereby prevents down-regulation of RHO1, whereas
inp51 or tax4 irs4 causes an increase in the level of PI(4,5)P2
that could then activate RHO1 via the pleckstrin homology
domain in the RHO1 GDP/GTP exchange factors.
The combined action of a GAP (SAC7) and a phosphoinositide
phosphatase (INP51) could be a conserved mechanism for achiev-
ing proper spatial and temporal regulation of a signaling path-
way, in this particular case signaling through the cell integrity
pathway. The GAP and phosphoinositide phosphatase combina-
tion has been observed in other organisms such as Dictyostelium
discoideum, where the phosphoinositide phosphatase Dd5P4 con-
tains both a PI(4,5)P2 5-phosphatase catalytic domain and a GAP
catalytic domain (68). This domain combination is also present in
the human PI(4,5)P2 5-phosphatase OCRL1 that, when mutated,
causes mental retardation and kidney and eye failure (oculoce-
rebrorenal Lowe syndrome) (69–71).
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